UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: regulation

The benefits of lysates vs live probiotic cultures in skincare

Numerous skincare brands incorporate lysates in their formulas. However, few brands are able to harness live and active bacteria in addition to the lysates. Neither is an easy task when it comes to formulation however, we can all acknowledge and appreciate the difficulty in working with live probiotics. So, what are the benefits and is this extra challenge worth the effort?

Read More

Positive Regulatory Developments for the U.S. Ag Tech Industry

2019 may prove to be propitious in terms of meaningful improvements to the regulatory strictures facing agricultural biotech and biologically based products.

In a move that will hopefully lead to positive changes in the regulatory situation facing ag biotech products, on June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.

Read More

A global perspective on the developments in biotech regulations

The ECJ ruling on GMOs has raised pertinent issues. How will it impact on current and future research? What are the optimum routes to progressing plant research?

In light of the ruling, it was a good time to welcome experts in policy and regulatory affairs to the recent 7th Plant Genomics & Gene Editing Congress: Europe to explore these issues. We’re lucky to be able to share this presentation from the event for those that weren’t able to make it. Watch it here.

Read More

The Top 5 Plant Genomics Articles of 2018

It has been an eventful year for plant genomics: we’ve seen advancements in plant disease research, the sequencing of the wheat genome, which was finally achieved through a worldwide collaboration of researchers spanning 13 years, and the ruling on the legal status of gene-edited crops. 

As 2018 draws to a close, we thought it was a good time to reflect. Here, we’ve collated our top articles of the year.

Read More

EU Court of Justice Rules that Gene Edited Organisms will be Regulated as GMOs

On 25 July 2018, the Court of Justice of the European Union, the EU’s highest court, issued a decision clarifying whether the EU would regulate products of innovative breeding techniques, like gene editing, under the EU’s Directive 2001/18, the principal EU law governing the regulation of GMOs.

Read More

Regulating Biostimulant Products

Degrading soil quality and increased interest in sustainable farming have caused the biostimulant market to go from strength-to-strength and it is expected to reach $4.14 billion by 2025. [1] Despite this, companies have expressed concerns that the regulation of biostimulants will hinder industry growth and the longevity of small companies and start-ups.

We spoke to Nick Moon, Global Regulatory Manager, Plant Impact, to discuss the regulation of biostimulants and its impact on industry.

Read More

Unraveling the Regulatory Quagmire of Agrobiologicals

At the Partnerships in Biocontrol, Biostimulants, & Microbiome: Europe, Peter Jens, Director of Strategic Alliances at Koppert Biological Systems and CEO of AND Biopharma, discussed regulation from product to systems thinking.

He focused specifically on the way in which consumers and citizens have become more vocal on the quality of products, arguing that the current regulatory discussion is fated and different thinking is required.

Here, he explains what he means by ‘different’ kinds of thinking and how this could help unravel the regulatory quagmire of agrochemicals and agrobiologicals.

Read More

The Long Shadow of the European Ruling on New Breeding Technologies

Last week, the European Court of Justice ruled that gene-edited crops are equivalent to transgenic GMOs. The court ruling came as a surprise because it negates a preliminary opinion that was issued by the court’s Advocate General Michael Bobek in January 2018. This reactionary ECJ ruling might become the final nail in the coffin of the European Agbiotech sector and many scientists, including myself, are concerned that it will discourage the use of genome editing in agriculture.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive